Taubman Institute leaders published in "Academic Medicine" journal
The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.
The article, Transforming Science Into Medicine: How Clinician-Scientists Can Build Bridges Across Research's 'Valley of Death," explores the problematic gap between bench research and clinical application of new treatments or cures. Despite significant increases in National Institutes of Health spending on medical research, this 'valley of death' persists.
That's due to the declining role of clinician-scientists, the authors state, noting the percentage of M.D.s receiving NIH funding has declined compared with Ph.Ds. The dearth requires radical action, including greater funding for translational research and more resources for the training, debt relief and early-career support of potential clinician-scientists.
The authors of the article are:
- Dr. Eva Feldman, director, A. Alfred Taubman Medical Research Institute
- Martin A. Fischhoff, managing director, A. Alfred Taubman Medical Research Institute
- Dr. Stacey Sakowski, deputy managing director, A. Alfred Taubman Medical Research Institute
- Scott Roberts, J.D., Dickinson Wright PLLC
Click here to read the entire article.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.




Donors pitch in to keep brilliant science minds at U-M Video